多发性骨髓瘤最新进展:第19届欧洲血液学会年会报道

摘要

Multiple myeloma is the second most common hematological malignancy.In the 19th European Hematology Association (EHA) conference,there are a number of hot and key topics focused on developing of MM diagnosis criteria,response evaluation,treatment strategy for elderly and relapse/refractory myeloma patients,and maintenance therapy etc.%多发性骨髓瘤是血液系统第二位常见恶性肿瘤.2014年欧洲血液学会年会围绕多发性骨髓瘤的最新诊断标准、疗效检测、老年人及复发难治骨髓瘤的治疗策略以及维持治疗的价值等多个内容均有精彩呈现.